Hormone receptors and HER2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway

Breast Journal

Volumn 20, Issue 3, 2014, Pages 308-311

  Adjei, Ernest K ^a,b   Owusu Afriyie, Osei ^a,b   Awuah, Baffour ^b   Stalsberg, Helge ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

Author keywords

Africa; breast cancer; erbB 2; Ghana; steroid receptors

Indexed keywords

DIAMINOBENZIDINE; EDETIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE OVEREXPRESSION; GHANA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NORWAY; PROTEIN EXPRESSION; QUALITY CONTROL; STANDARDIZATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR BIOPSY; TUMOR INVASION; TUMOR VOLUME; AFRICA SOUTH OF THE SAHARA; BREAST TUMOR; FEMALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AFRICA SOUTH OF THE SAHARA; BREAST NEOPLASMS; FEMALE; GHANA; HUMANS; MIDDLE AGED; NORWAY; RECEPTOR, ERBB-2; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84899479494     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12261     Document Type: Article

References (14)

1. Huo D, Ikpatt F, Khramtsov A, et al,. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-21.
2. Gukas ID, Jennings BA, Mandong BM, et al,. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 2005; 24: 209-13.
3. Bird PA, Hill AG, Houssami N,. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008; 15: 1983-8.
4. Stark A, Kleer CG, Martin I, et al,. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 2010; 116: 4926-32.
5. Adisa CA, Eleweke N, Alfred AA, et al,. Biology of breast cancer in Nigerian women. A pilot study. Ann Afr Med 2012; 11: 169-75.
6. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE,. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 2008; 110: 183-8.
7. Awadelkarim KD, Arizzi C, Elamin EO, et al,. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 2008; 52: 445-56.
8. Roy I, Othieno E,. Breast carcinoma in Uganda. Microscopic study and receptor profile of 45 cases. Arch Pathol Lab Med 2011; 135: 194-9.
9. Elston CW, Ellis IO,. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
10. Hammond ME, Hayes DF, Dowsett M, et al,. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 2010; 134: e48-72.
11. Yarney J, Vanderpuye V, Clegg-Lamptey JN,. Hormone receptor and HER-2 expression in breast cancers among Sub-Saharan African women. Breast J 2008; 1: 510-1.
12. Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD,. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 1996; 74: 1445-51.
13. Nyagol J, Nyong'o A, Byakika B, et al,. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 2006; 26: 97-103.
14. Ugiagbe EE, Olu-Eddo AN, Obaseki DE,. Immunohistochemical detection of Her-2/neu overexpression in breast carcinoma in Nigerians. A 5-year retrospective study. Niger J Clin Pract 2011; 14: 332-7.